Oncolytics Shares Leap For Second Straight Day On High Volume

Shares of cancer-treatment developer Oncolytics Biotech Inc. (ONCY) have soared this week as increased attention has led to growing excitement about the company's pivotal upcoming clinical trial for its head and neck cancer treatment.

Shares of the Calgary company were recently up 11% to $2.90 on nearly six times their typical trading volumes, a day after jumping 9.6% on nearly three times the typical amount of trading. (Read More)

Source: Wall Street Journal